| Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. | |
| | |
MedLine Citation:
|
PMID: 18991338 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Alzheimer's disease (AD) is found at autopsy in up to one third of patients with primary progressive aphasia (PPA), but clinical features that predict AD pathology in PPA are not well defined. We studied the relationships between language presentation, Abeta amyloidosis, and glucose metabolism in three PPA variants using [11C]-Pittsburgh compound B ([11C]PIB) and [18F]-labeled fluorodeoxyglucose positron emission tomography ([18F]FDG-PET). METHODS: Patients meeting PPA criteria (N = 15) were classified as logopenic aphasia (LPA), progressive nonfluent aphasia (PNFA), or semantic dementia (SD) based on language testing. [11C]PIB distribution volume ratios were calculated using Logan graphical analysis (cerebellar reference). [18F]FDG images were normalized to pons. Partial volume correction was applied. RESULTS: Elevated cortical PIB (by visual inspection) was more common in LPA (4/4 patients) than in PNFA (1/6) and SD (1/5) (p < 0.02). In PIB-positive PPA, PIB uptake was diffuse and indistinguishable from the pattern in matched AD patients (n = 10). FDG patterns were focal and varied by PPA subtype, with left temporoparietal hypometabolism in LPA, left frontal hypometabolism in PNFA, and left anterior temporal hypometabolism in SD. FDG uptake was significant asymmetric (favoring left hypometabolism) in PPA (p < 0.005) but not in AD. INTERPRETATION: LPA is associated with Abeta amyloidosis, suggesting that subclassification of PPA based on language features can help predict the likelihood of AD pathology. Language phenotype in PPA is closely related to metabolic changes that are focal and anatomically distinct between subtypes, but not to amyloid deposition patterns that are diffuse and similar to AD. |
| | |
Authors:
|
Gil D Rabinovici; William J Jagust; Ansgar J Furst; Jennifer M Ogar; Caroline A Racine; Elizabeth C Mormino; James P O'Neil; Rayhan A Lal; Nina F Dronkers; Bruce L Miller; Maria Luisa Gorno-Tempini |
Related Documents
:
|
7588938 - Assessment of systolic wall thickening using technetium-99m methoxyisobutylisonitrile i... 7915828 - A comparison of adenosine and exercise stress 201t1 scintigraphy. 7552528 - Simple hyperaemia test as a screening method in the postoperative surveillance of infra... 8510308 - Ratio of lung to heart thallium-201 uptake on exercise and dipyridamole stress imaging ... 15879168 - Influence of muscle glycogen availability on erk1/2 and akt signaling after resistance ... 2968418 - A pubococcygeal exercise program for simple urinary stress incontinence: applicability ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Annals of neurology Volume: 64 ISSN: 1531-8249 ISO Abbreviation: Ann. Neurol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-11-13 Completed Date: 2008-12-24 Revised Date: 2011-08-01 |
Medline Journal Info:
|
Nlm Unique ID: 7707449 Medline TA: Ann Neurol Country: United States |
Other Details:
|
Languages: eng Pagination: 388-401 Citation Subset: IM |
Affiliation:
|
Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA. grabinovici@memory.ucsf.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Alzheimer Disease / metabolism, radionuclide imaging Amyloid beta-Peptides / metabolism* Analysis of Variance Aniline Compounds / metabolism Aphasia, Primary Progressive / classification*, metabolism*, radionuclide imaging Carbon Isotopes / metabolism Dementia / metabolism, radionuclide imaging Female Fluorodeoxyglucose F18 / metabolism Glucose / metabolism* Humans Image Processing, Computer-Assisted Language Language Tests Male Middle Aged Positron-Emission Tomography / methods Thiazoles / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
AG027859/AG/NIA NIH HHS; K23 AG031861-04/AG/NIA NIH HHS; P01-AG1972403/AG/NIA NIH HHS; P50-AG023501/AG/NIA NIH HHS; R01 AG027859-01A1/AG/NIA NIH HHS; R01-NS050915/NS/NINDS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; 0/Amyloid beta-Peptides; 0/Aniline Compounds; 0/Carbon Isotopes; 0/Thiazoles; 50-99-7/Glucose; 63503-12-8/Fluorodeoxyglucose F18 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Covalently-linked hyaluronan promotes bone formation around Ti implants in a rabbit model.
Next Document: Lung function in 3-5-year-old children with cystic fibrosis.